Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Glycerolipid metabolism (mmu00561)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
2310005E
10Rik
KLA  ATP  ATP+KLA
 BC026843 RIKEN cDNA 2310005E10 gene, mRNA (cDNA clone IMAGE:4487182), complete cds. [BC026843] KLA .70 .65 .65 .65 .83 .90 .89
ATP 1.00 .95 .75 .31 .29 .58 .80
KLA/ATP .69 .54 .49 .28 .36 .56 .53
2310005E
10Rik
KLA  ATP  ATP+KLA
 NM_172398 RIKEN cDNA 2310005E10 gene (2310005E10Rik), mRNA [NM_172398] KLA .78 .71 .71 .71 .69 .90 .82
ATP 1.01 .95 1.18 .89 .68 .44 .62
KLA/ATP .71 .70 .88 .67 .60 .59 .63
6720408I
04Rik
KLA  ATP  ATP+KLA
 AK020107 12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720408I04 product:hypothetical protein, full insert sequence. [AK020107] KLA .92 1.01 1.02 .96 .93 1.00 .99
ATP 1.00 .94 .90 .94 1.01 1.01 .98
KLA/ATP 1.00 .95 .92 .94 1.01 .97 .95
A530057A
03Rik
KLA  ATP  ATP+KLA
 NM_001081089 RIKEN cDNA A530057A03 gene (A530057A03Rik), mRNA [NM_001081089] KLA 1.06 1.10 1.05 1.03 1.12 1.14 1.27
ATP 1.04 1.11 1.07 1.01 .97 .99 1.06
KLA/ATP 1.10 1.19 1.14 .96 1.11 .91 1.09
Agk
KLA  ATP  ATP+KLA
 NM_023538 acylglycerol kinase (Agk), mRNA [NM_023538] KLA 1.16 1.30 1.23 1.15 .96 .85 .86
ATP .97 .99 .99 1.04 .92 .88 .81
KLA/ATP 1.15 1.25 1.25 1.39 1.09 .93 .56
Agpat1
KLA  ATP  ATP+KLA
 NM_018862 1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha) (Agpat1), mRNA [NM_018862] KLA 1.24 1.27 1.16 1.37 1.37 1.51 1.65
ATP .99 1.09 1.19 1.29 1.20 1.03 1.27
KLA/ATP 1.27 1.33 1.37 1.49 1.28 1.17 1.55
Agpat2
KLA  ATP  ATP+KLA
 NM_026212 1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) (Agpat2), mRNA [NM_026212] KLA .88 .86 1.05 1.00 1.28 1.13 1.05
ATP 1.06 1.15 .95 1.09 .97 1.22 1.04
KLA/ATP .96 .94 .73 .87 .78 .97 .63
Agpat3
KLA  ATP  ATP+KLA
 NM_053014 1-acylglycerol-3-phosphate O-acyltransferase 3 (Agpat3), mRNA [NM_053014] KLA 1.13 1.10 1.05 1.19 1.28 1.33 1.53
ATP .95 .95 .89 .84 .79 .82 1.41
KLA/ATP .95 1.03 1.08 .94 .77 .75 1.42
Agpat4
KLA  ATP  ATP+KLA
 NM_026644 1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) (Agpat4), mRNA [NM_026644] KLA 1.37 1.26 1.06 1.10 .98 1.29 1.77
ATP 1.05 .95 1.02 1.26 1.86 3.88 2.42
KLA/ATP 1.38 1.32 1.44 1.22 1.29 2.06 5.07
Agpat6
KLA  ATP  ATP+KLA
 NM_018743 1-acylglycerol-3-phosphate O-acyltransferase 6 (lysophosphatidic acid acyltransferase, zeta) (Agpat6), mRNA [NM_018743] KLA 1.14 1.08 1.21 1.15 1.17 1.25 1.50
ATP 1.05 1.02 .91 .91 1.11 1.42 1.26
KLA/ATP 1.16 1.17 .96 .87 1.00 1.40 1.35
Agpat9
KLA  ATP  ATP+KLA
 NM_172715 1-acylglycerol-3-phosphate O-acyltransferase 9 (Agpat9), transcript variant 1, mRNA [NM_172715] KLA .69 .70 .67 .64 .61 .61 .79
ATP .89 .77 .69 .57 2.26 2.30 1.90
KLA/ATP .67 .66 .68 .56 1.39 1.82 1.98
AK165218
KLA  ATP  ATP+KLA
 AK165218 6 days neonate spleen cDNA, RIKEN full-length enriched library, clone:F420008K05 product:lipin 2, full insert sequence. [AK165218] KLA .96 .94 .83 1.03 1.08 .97 1.07
ATP 1.20 1.84 1.52 2.12 1.12 1.23 1.14
KLA/ATP .97 1.03 1.17 1.13 .98 1.07 1.21
Akr1a4
KLA  ATP  ATP+KLA
 NM_021473 aldo-keto reductase family 1, member A4 (aldehyde reductase) (Akr1a4), mRNA [NM_021473] KLA .96 1.00 1.13 .96 1.13 1.16 1.43
ATP 1.06 1.07 .77 .94 .86 1.17 2.12
KLA/ATP 1.06 1.03 .65 .93 .85 1.38 2.61
Akr1b3
KLA  ATP  ATP+KLA
 AK054167 2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230024H01 product:unclassifiable, full insert sequence [AK054167] KLA 1.06 .92 .98 1.01 1.02 1.04 .96
ATP 1.08 1.02 .99 .97 1.09 1.02 .99
KLA/ATP .99 1.01 .97 .99 1.02 .99 1.08
Akr1b3
KLA  ATP  ATP+KLA
 NM_009658 aldo-keto reductase family 1, member B3 (aldose reductase) (Akr1b3), mRNA [NM_009658] KLA .97 .99 .96 .91 .92 .93 .77
ATP 1.08 1.13 1.09 1.15 1.00 1.03 1.18
KLA/ATP 1.06 .98 .95 1.15 .89 .88 .82
Akr1b7
KLA  ATP  ATP+KLA
 NM_009731 aldo-keto reductase family 1, member B7 (Akr1b7), mRNA [NM_009731] KLA .92 .93 .93 .93 .97 .96 .84
ATP .97 1.01 .93 .88 .85 .95 .88
KLA/ATP .86 .92 .92 .82 .85 .94 1.02
Akr1b8
KLA  ATP  ATP+KLA
 NM_008012 aldo-keto reductase family 1, member B8 (Akr1b8), mRNA [NM_008012] KLA .64 .56 .49 .46 .31 .25 .25
ATP .95 .97 1.17 .90 .85 2.25 2.02
KLA/ATP .55 .53 .63 .47 .50 1.00 2.18
Aldh1b1
KLA  ATP  ATP+KLA
 NM_028270 aldehyde dehydrogenase 1 family, member B1 (Aldh1b1), nuclear gene encoding mitochondrial protein, mRNA [NM_028270] KLA 7.51 7.83 9.27 11.57 11.10 10.78 4.79
ATP .93 .91 .90 .89 .73 2.27 2.30
KLA/ATP 6.45 7.40 9.33 9.54 8.82 12.15 10.67
Aldh2
KLA  ATP  ATP+KLA
 AK163452 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230105J09 product:aldehyde dehydrogenase 2, mitochondrial, full insert sequence [AK163452] KLA .62 .65 .59 .60 .63 .64 .49
ATP 1.01 .91 1.06 .93 1.18 .93 .41
KLA/ATP .70 .68 .70 .84 1.16 .96 .45
Aldh2
KLA  ATP  ATP+KLA
 NM_009656 aldehyde dehydrogenase 2, mitochondrial (Aldh2), nuclear gene encoding mitochondrial protein, mRNA [NM_009656] KLA .74 .81 .77 .65 .60 .53 .50
ATP .98 1.10 .90 1.17 1.04 .82 .60
KLA/ATP .84 .86 .77 .82 .72 .66 .51
Aldh3a2
KLA  ATP  ATP+KLA
 NM_007437 aldehyde dehydrogenase family 3, subfamily A2 (Aldh3a2), mRNA [NM_007437] KLA .86 .83 .79 .79 .80 .97 1.00
ATP .93 .98 .94 .89 .77 .87 1.02
KLA/ATP .78 .81 .67 .72 .65 .81 .97
Aldh7a1
KLA  ATP  ATP+KLA
 NM_138600 aldehyde dehydrogenase family 7, member A1 (Aldh7a1), mRNA [NM_138600] KLA .98 1.03 1.08 1.12 1.08 .94 .99
ATP 1.01 1.03 1.00 1.03 .98 .82 .91
KLA/ATP 1.15 1.12 1.01 1.02 .90 .89 .83
Aldh9a1
KLA  ATP  ATP+KLA
 NM_019993 aldehyde dehydrogenase 9, subfamily A1 (Aldh9a1), mRNA [NM_019993] KLA .64 .64 .67 .48 .42 .24 .33
ATP 1.07 1.02 .75 .94 .68 .46 .42
KLA/ATP .72 .65 .43 .55 .37 .31 .24
Cel
KLA  ATP  ATP+KLA
 NM_009885 carboxyl ester lipase (Cel), mRNA [NM_009885] KLA 1.06 1.02 1.06 1.07 1.07 1.08 1.11
ATP 1.01 1.04 1.18 1.09 1.09 1.21 1.09
KLA/ATP 1.06 .97 1.24 1.16 1.19 1.21 1.10
Dak
KLA  ATP  ATP+KLA
 NM_145496 dihydroxyacetone kinase 2 homolog (yeast) (Dak), mRNA [NM_145496] KLA 1.00 1.03 1.04 .98 1.06 .90 .85
ATP 1.13 1.16 .89 1.01 .74 .67 .85
KLA/ATP 1.07 1.07 .90 .98 .66 .56 .81
Dgat1
KLA  ATP  ATP+KLA
 NM_010046 diacylglycerol O-acyltransferase 1 (Dgat1), mRNA [NM_010046] KLA 1.05 1.03 1.09 .93 1.04 1.06 1.42
ATP 1.06 1.12 1.23 1.57 1.34 2.37 1.50
KLA/ATP 1.11 1.10 .97 1.24 1.10 2.12 2.03
Dgat2
KLA  ATP  ATP+KLA
 NM_026384 diacylglycerol O-acyltransferase 2 (Dgat2), mRNA [NM_026384] KLA 2.44 2.65 2.86 3.52 3.45 2.83 1.41
ATP .97 .97 1.07 1.81 1.69 2.29 1.29
KLA/ATP 2.21 2.45 2.36 2.76 3.16 4.51 3.63
Dgka
KLA  ATP  ATP+KLA
 NM_016811 diacylglycerol kinase, alpha (Dgka), mRNA [NM_016811] KLA 3.34 3.15 3.23 3.20 2.95 1.29 .45
ATP 1.11 .97 1.01 .90 1.32 1.39 1.33
KLA/ATP 2.97 3.42 3.95 2.85 2.49 1.47 1.21
Dgkb
KLA  ATP  ATP+KLA
 AK032509 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430574F24 product:DIACYLGLYCEROL KINASE, BETA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- BETA) (DAG KINASE BETA) (90 KDA DIACYLGLYCEROL KINASE) homolog [Rattus nor KLA .92 .92 .98 .93 1.01 1.06 1.00
ATP 1.03 1.05 .97 1.00 .95 1.03 .99
KLA/ATP 1.00 1.07 1.02 .97 1.00 .96 .97
Dgkb
KLA  ATP  ATP+KLA
 AK083222 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630029D13 product:DIACYLGLYCEROL KINASE, BETA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- BETA) (DAG KINASE BETA) (90 KDA DIACYLGLYCEROL KINASE) homolog [Rattus norvegi KLA 1.02 1.02 1.12 1.01 1.00 1.05 .99
ATP .97 1.01 1.06 .95 1.07 1.03 1.03
KLA/ATP .95 .99 1.05 1.02 1.04 .96 1.06
Dgkb
KLA  ATP  ATP+KLA
 AK122355 mRNA for mKIAA0718 protein [AK122355] KLA 1.03 .96 1.11 1.02 .95 .94 .97
ATP 1.00 .99 1.09 1.01 1.02 .96 .95
KLA/ATP .97 1.00 1.05 1.03 .95 1.02 .95
Dgkb
KLA  ATP  ATP+KLA
 NM_178681 diacylglycerol kinase, beta (Dgkb), mRNA [NM_178681] KLA 1.05 1.08 1.03 1.04 .94 1.01 1.04
ATP 1.04 1.02 1.04 .95 1.01 1.03 1.05
KLA/ATP 1.09 .95 1.00 1.03 1.06 1.05 1.05
Dgkd
KLA  ATP  ATP+KLA
 AK076439 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832425N18 product:DIACYLGLYCEROL KINASE, DELTA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK-DELTA) (DAG KINASE DELTA) (130 KDA DIACYLGLYCEROL KINASE) (FRAGMENT) homolog [Homo KLA .43 .42 .38 .38 .44 .36 .28
ATP 1.08 1.06 .96 1.28 1.01 .42 .25
KLA/ATP .42 .41 .38 .39 .46 .40 .23
Dgkd
KLA  ATP  ATP+KLA
 AK172901 mRNA for mKIAA0145 protein [AK172901] KLA .27 .25 .22 .22 .23 .23 .22
ATP .87 .79 .81 .66 .58 .34 .31
KLA/ATP .22 .22 .19 .15 .20 .22 .15
Dgke
KLA  ATP  ATP+KLA
 NM_019505 diacylglycerol kinase, epsilon (Dgke), mRNA [NM_019505] KLA 1.17 1.16 1.09 .92 .86 .99 1.25
ATP 1.02 1.01 .92 .79 .99 1.14 1.10
KLA/ATP 1.19 1.16 .98 .87 .97 1.05 .88
Dgkg
KLA  ATP  ATP+KLA
 AK089261 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630107L03 product:SIMILAR TO DIACYLGLYCEROL KINASE 3 (GAMMA) homolog [Mus musculus], full insert sequence. [AK089261] KLA .95 .91 .97 .98 .97 .93 .96
ATP 1.04 1.02 .96 .93 .98 .89 .88
KLA/ATP 1.02 .99 .92 .86 .95 .92 .90
Dgkg
KLA  ATP  ATP+KLA
 NM_138650 diacylglycerol kinase, gamma (Dgkg), mRNA [NM_138650] KLA .65 .64 .62 .78 .86 .68 .53
ATP .92 .99 1.04 .83 .67 .71 .55
KLA/ATP .60 .66 .66 .65 .84 1.00 .59
Dgkh
KLA  ATP  ATP+KLA
 AK031069 13 days embryo forelimb cDNA, RIKEN full-length enriched library, clone:5930402B05 product:DIACYLGLYCEROL KINASE, DELTA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- DELTA) (DAG KINASE DELTA) (130 KDA DIACYLGLYCEROL KINASE) (DIACYLGLYCEROL KI KLA 3.02 2.91 2.42 2.25 1.93 1.46 1.40
ATP 1.04 1.08 1.10 1.28 1.46 1.35 .98
KLA/ATP 3.66 4.04 3.53 1.88 1.69 1.34 1.47
Dgkh
KLA  ATP  ATP+KLA
 NM_001081336 diacylglycerol kinase, eta (Dgkh), mRNA [NM_001081336] KLA 6.71 7.34 7.44 7.69 6.90 4.13 3.15
ATP .98 .96 1.02 1.20 2.01 3.95 2.09
KLA/ATP 6.79 7.17 6.53 7.03 4.73 5.21 5.62
Dgki
KLA  ATP  ATP+KLA
 AK086550 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930036J18 product:DIACYLGLYCEROL KINASE, IOTA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- IOTA) (DAG KINASE IOTA) homolog [Homo sapiens], full insert sequence. [AK086550] KLA 1.03 1.00 .96 1.07 1.00 1.08 .95
ATP 1.06 .99 1.02 .96 .98 1.02 1.03
KLA/ATP .99 .99 .99 .97 .99 .92 .99
Dgki
KLA  ATP  ATP+KLA
 NM_001081206 diacylglycerol kinase, iota (Dgki), mRNA [NM_001081206] KLA .99 .96 .89 .99 .92 .98 1.02
ATP 1.00 1.01 .95 1.00 .95 .90 1.02
KLA/ATP .91 .86 1.02 .99 1.02 .90 .98
Dgkq
KLA  ATP  ATP+KLA
 NM_199011 diacylglycerol kinase, theta (Dgkq), mRNA [NM_199011] KLA 1.09 .95 1.05 .98 .93 .96 1.11
ATP .99 .78 .66 .44 .99 1.04 1.23
KLA/ATP .98 .73 .66 .47 .67 .89 1.15
Dgkz
KLA  ATP  ATP+KLA
 NM_138306 diacylglycerol kinase zeta (Dgkz), mRNA [NM_138306] KLA .21 .22 .23 .29 .56 1.23 1.39
ATP 1.08 1.25 .90 1.22 .85 .57 1.44
KLA/ATP .23 .22 .18 .31 .60 .80 1.45
Gk2
KLA  ATP  ATP+KLA
 NM_010294 glycerol kinase 2 (Gk2), mRNA [NM_010294] KLA 1.26 1.28 1.65 1.55 1.96 1.59 1.41
ATP .99 1.02 1.00 1.17 1.20 1.63 1.06
KLA/ATP 1.39 1.49 1.34 1.36 1.21 1.45 1.30
Gla
KLA  ATP  ATP+KLA
 NM_013463 galactosidase, alpha (Gla), mRNA [NM_013463] KLA .91 .95 1.02 .93 1.02 1.35 1.99
ATP 1.06 1.22 1.08 1.49 1.31 1.44 3.32
KLA/ATP 1.01 1.05 .89 1.54 1.26 1.98 5.13
Gla
KLA  ATP  ATP+KLA
 U34071 alpha-galactosidase A mRNA, complete cds. [U34071] KLA .99 .99 1.18 1.28 1.30 1.59 1.66
ATP 1.12 1.20 1.32 1.74 1.93 1.44 1.50
KLA/ATP 1.12 1.24 1.28 1.98 2.55 2.85 2.82
Glyctk
KLA  ATP  ATP+KLA
 NM_174846 glycerate kinase (Glyctk), transcript variant 1, mRNA [NM_174846] KLA .98 1.05 1.12 1.07 1.13 1.16 1.11
ATP 1.04 1.07 .93 .93 .72 .97 1.22
KLA/ATP 1.02 1.02 .94 .89 .82 1.00 1.26
Gpam
KLA  ATP  ATP+KLA
 NM_008149 glycerol-3-phosphate acyltransferase, mitochondrial (Gpam), nuclear gene encoding mitochondrial protein, mRNA [NM_008149] KLA 1.04 .97 1.00 1.04 .90 .96 1.00
ATP .98 1.18 1.10 .95 .70 .98 1.37
KLA/ATP 1.03 1.06 1.05 1.01 .79 .89 1.00
Gyk
KLA  ATP  ATP+KLA
 AK037633 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130030N17 product:unclassifiable, full insert sequence [AK037633] KLA 5.44 4.98 5.36 4.61 4.88 2.89 1.97
ATP 1.17 1.65 4.22 2.33 6.88 2.27 1.07
KLA/ATP 5.99 9.29 15.97 4.69 3.09 3.74 2.06
Gyk
KLA  ATP  ATP+KLA
 AK086200 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930012N15 product:glycerol kinase, full insert sequence. [AK086200] KLA 1.16 1.08 1.12 1.03 1.02 1.07 .98
ATP .93 1.01 1.12 .95 1.14 .96 .98
KLA/ATP 1.23 1.24 1.22 .95 1.10 .96 1.06
Gyk
KLA  ATP  ATP+KLA
 NM_008194 glycerol kinase (Gyk), transcript variant 1, mRNA [NM_008194] KLA 2.56 2.95 3.62 4.16 5.93 5.02 2.77
ATP 1.04 1.19 1.02 1.51 2.16 4.68 1.09
KLA/ATP 2.65 2.96 2.71 4.15 2.62 4.18 3.09
Gyk
KLA  ATP  ATP+KLA
 NM_212444 glycerol kinase (Gyk), transcript variant 2, mRNA [NM_212444] KLA 3.95 4.35 5.39 5.59 8.90 6.88 3.32
ATP 1.12 1.38 1.20 1.70 2.32 4.01 .95
KLA/ATP 3.99 4.03 4.00 5.56 2.86 3.73 3.14
Lipc
KLA  ATP  ATP+KLA
 NM_008280 lipase, hepatic (Lipc), mRNA [NM_008280] KLA 1.00 1.01 .96 .99 1.01 1.06 1.05
ATP 1.02 1.03 1.15 .98 .93 1.03 .89
KLA/ATP 1.04 .92 1.07 .98 .99 .93 1.00
Lipf
KLA  ATP  ATP+KLA
 NM_026334 lipase, gastric (Lipf), mRNA [NM_026334] KLA .98 1.00 1.09 1.07 1.04 1.12 1.11
ATP .96 .98 1.02 1.03 1.00 .99 1.05
KLA/ATP 1.03 1.05 .99 1.03 1.04 1.08 1.05
Lipg
KLA  ATP  ATP+KLA
 NM_010720 lipase, endothelial (Lipg), mRNA [NM_010720] KLA 10.93 11.98 13.48 13.21 13.64 13.36 3.84
ATP 1.02 .97 1.44 1.72 1.38 1.91 1.52
KLA/ATP 11.30 13.74 13.52 14.68 10.21 9.64 10.43
Lpin1
KLA  ATP  ATP+KLA
 AF180471 Lpin1 (Kiaa0188) mRNA, complete cds [AF180471] KLA .26 .24 .29 .31 .26 .25 .24
ATP 1.23 .96 1.11 .97 .82 .43 .62
KLA/ATP .27 .25 .42 .37 .49 .34 .22
Lpin1
KLA  ATP  ATP+KLA
 NM_015763 lipin 1 (Lpin1), transcript variant 2, mRNA [NM_015763] KLA .19 .19 .18 .20 .18 .16 .19
ATP 1.02 .99 1.06 .93 .70 .35 .70
KLA/ATP .18 .17 .27 .25 .30 .25 .16
Lpin3
KLA  ATP  ATP+KLA
 NM_022883 lipin 3 (Lpin3), mRNA [NM_022883] KLA .99 .98 1.06 1.04 1.01 .99 .99
ATP 1.03 1.01 1.02 .92 1.00 1.03 .91
KLA/ATP 1.03 .97 .99 .99 .92 .91 1.02
Lpl
KLA  ATP  ATP+KLA
 NM_008509 lipoprotein lipase (Lpl), mRNA [NM_008509] KLA .81 .81 .89 .76 .77 .71 .76
ATP 1.10 1.07 .65 .45 .37 .24 .62
KLA/ATP .89 .90 .56 .40 .29 .21 .23
Lycat
KLA  ATP  ATP+KLA
 NM_001081071 lysocardiolipin acyltransferase (Lycat), mRNA [NM_001081071] KLA 1.03 .96 1.02 .97 1.02 .94 .99
ATP 1.09 1.08 .99 .94 .75 .90 1.06
KLA/ATP 1.02 1.10 .98 .91 .73 .97 1.03
Mboat1
KLA  ATP  ATP+KLA
 NM_153546 membrane bound O-acyltransferase domain containing 1 (Mboat1), mRNA [NM_153546] KLA .55 .57 .44 .39 .23 .14 .12
ATP .86 .94 1.05 1.04 .90 .52 .14
KLA/ATP .53 .53 .55 .53 .46 .35 .12
Mboat2
KLA  ATP  ATP+KLA
 AK031682 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030487B18 product:unclassifiable, full insert sequence [AK031682] KLA .94 .98 .99 .97 .92 1.08 1.08
ATP 1.00 .99 1.05 1.01 1.03 1.01 1.07
KLA/ATP 1.02 1.06 .99 1.06 1.08 1.14 .96
Mboat2
KLA  ATP  ATP+KLA
 NM_026037 membrane bound O-acyltransferase domain containing 2 (Mboat2), transcript variant 1, mRNA [NM_026037] KLA .84 .87 .81 .81 .81 .83 .95
ATP 1.03 1.01 1.04 1.01 1.10 1.02 .88
KLA/ATP .89 .88 .98 .91 .89 1.01 1.11
Mgll
KLA  ATP  ATP+KLA
 NM_011844 monoglyceride lipase (Mgll), mRNA [NM_011844] KLA .86 .83 .81 .85 .67 .57 .46
ATP 1.02 1.00 1.15 1.16 1.26 1.27 .74
KLA/ATP .90 .85 1.01 1.05 1.26 1.20 .71
Mm.22792
4
KLA  ATP  ATP+KLA
 142373198 Unknown KLA 1.61 1.61 1.22 1.43 1.87 1.90 1.75
ATP 1.08 1.06 1.09 2.61 2.93 1.89 2.18
KLA/ATP 1.40 1.68 1.35 1.68 1.51 1.39 2.31
Mm.24244
KLA  ATP  ATP+KLA
 23956161 Unknown KLA 1.04 1.00 .96 1.04 1.53 1.13 1.09
ATP 1.17 1.30 .97 1.10 1.09 1.26 1.10
KLA/ATP .92 1.07 .82 .97 .80 .96 .74
Mm.28873
KLA  ATP  ATP+KLA
 110431340 Unknown KLA .79 .72 .69 .71 .44 .32 .37
ATP .89 .88 1.17 .98 1.11 .98 .73
KLA/ATP .67 .72 .87 .74 .75 .53 .30
Mm.32919
4
KLA  ATP  ATP+KLA
 124486721 Unknown KLA 1.02 .91 .92 .99 .85 .96 .84
ATP .97 .92 1.29 .82 .56 1.00 .95
KLA/ATP .90 .98 1.13 .79 .71 1.06 .84
Mm.41173
7
KLA  ATP  ATP+KLA
 124486740 Unknown KLA 6.95 6.26 6.49 5.66 6.34 2.93 3.01
ATP 1.18 1.40 1.03 1.27 1.96 1.87 1.53
KLA/ATP 6.62 7.00 6.07 6.81 2.75 2.22 2.84
Mm.44250
5
KLA  ATP  ATP+KLA
 124487070 Unknown KLA .93 .96 1.03 1.01 .97 .93 1.17
ATP 1.04 .91 .96 .96 .99 .89 .96
KLA/ATP .95 .89 .70 1.01 .95 1.00 .96
Pnlip
KLA  ATP  ATP+KLA
 AK007357 10 day old male pancreas cDNA, RIKEN full-length enriched library, clone:1810007A24 product:PANCREATIC TRIGLYCERIDE LIPASE (FRAGMENT) homolog [Rattus norvegicus], full insert sequence. [AK007357] KLA .95 1.03 1.02 1.02 1.04 1.06 1.10
ATP 1.05 1.00 .95 1.10 1.00 1.03 1.02
KLA/ATP 1.02 1.00 .89 1.09 1.09 1.06 1.06
Pnlip
KLA  ATP  ATP+KLA
 NM_026925 pancreatic lipase (Pnlip), mRNA [NM_026925] KLA 1.04 .97 1.04 1.00 1.02 .99 .97
ATP 1.04 1.04 1.04 .96 .95 1.02 .97
KLA/ATP .99 .95 .97 .99 .96 .93 1.00
Pnliprp1
KLA  ATP  ATP+KLA
 NM_018874 pancreatic lipase related protein 1 (Pnliprp1), mRNA [NM_018874] KLA .99 .95 .96 .99 .94 .96 1.01
ATP 1.00 1.00 .98 .96 .99 .87 1.09
KLA/ATP 1.01 1.06 1.01 1.02 1.03 .96 .92
Pnliprp2
KLA  ATP  ATP+KLA
 NM_011128 pancreatic lipase-related protein 2 (Pnliprp2), mRNA [NM_011128] KLA 1.01 .97 1.02 1.07 1.08 .98 1.00
ATP 1.05 1.08 .98 1.02 1.00 1.00 1.02
KLA/ATP 1.05 1.04 .96 .99 1.01 1.03 1.05
Pnpla2
KLA  ATP  ATP+KLA
 NM_025802 patatin-like phospholipase domain containing 2 (Pnpla2), mRNA [NM_025802] KLA 1.18 1.27 1.25 1.09 1.15 1.14 1.19
ATP 1.05 1.17 1.05 1.82 1.47 1.41 1.10
KLA/ATP 1.34 1.41 1.13 1.96 1.63 1.83 1.72
Pnpla3
KLA  ATP  ATP+KLA
 NM_054088 patatin-like phospholipase domain containing 3 (Pnpla3), mRNA [NM_054088] KLA .88 .99 1.04 .97 1.00 .91 1.03
ATP .95 1.03 1.05 1.03 1.01 .93 .99
KLA/ATP 1.02 1.05 1.00 .94 .95 .98 .95
Ppap2a
KLA  ATP  ATP+KLA
 NM_008903 phosphatidic acid phosphatase 2a (Ppap2a), transcript variant 2, mRNA [NM_008903] KLA 2.62 2.86 4.01 5.61 7.84 10.88 16.35
ATP 1.01 1.02 1.09 1.28 1.27 2.38 1.44
KLA/ATP 2.78 2.78 2.99 3.43 2.85 3.59 6.59
Ppap2b
KLA  ATP  ATP+KLA
 NM_080555 phosphatidic acid phosphatase type 2B (Ppap2b), mRNA [NM_080555] KLA 2.73 2.72 2.65 2.39 1.07 1.48 3.26
ATP .99 .97 1.60 2.76 18.64 27.23 9.19
KLA/ATP 2.69 2.80 4.36 4.20 14.33 15.32 17.91
Ppap2c
KLA  ATP  ATP+KLA
 NM_015817 phosphatidic acid phosphatase type 2c (Ppap2c), mRNA [NM_015817] KLA .94 .88 .91 .79 .65 .46 .51
ATP 1.01 1.03 1.00 1.12 1.24 .90 .83
KLA/ATP .95 .93 .87 .95 .79 .63 .43